Creoptix develops optical instruments and consumables for the label-free analysis of molecular interactions for the drug discovery industry.
Creoptix has raised €7.2M across 1 funding round from 1 investor, most recently a Series C round in Jul 2019. Based in Wadenswil, Switzerland; founded 2009; active in Healthtech. Data as of 7 Aug 2026.
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2019-07-01 | Series C |
| €7.2M |
| Zürcher Kantonalbank ZKB |
| View deal → |
